151 related articles for article (PubMed ID: 28758949)
1. Potential New Non-Invasive Therapy Using Artificial Oxygen Carriers for Pre-Eclampsia.
Ohta H; Kaga M; Li H; Sakai H; Okamura K; Yaegashi N
J Funct Biomater; 2017 Jul; 8(3):. PubMed ID: 28758949
[TBL] [Abstract][Full Text] [Related]
2. Artificial oxygen carriers rescue placental hypoxia and improve fetal development in the rat pre-eclampsia model.
Li H; Ohta H; Tahara Y; Nakamura S; Taguchi K; Nakagawa M; Oishi Y; Goto Y; Wada K; Kaga M; Inagaki M; Otagiri M; Yokota H; Shibata S; Sakai H; Okamura K; Yaegashi N
Sci Rep; 2015 Oct; 5():15271. PubMed ID: 26471339
[TBL] [Abstract][Full Text] [Related]
3. Placental expression of vascular endothelial growth factor in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction does not support placental hypoxia at delivery.
Lyall F; Young A; Boswell F; Kingdom JC; Greer IA
Placenta; 1997 May; 18(4):269-76. PubMed ID: 9179920
[TBL] [Abstract][Full Text] [Related]
4. Placental-specific sFLT-1: role in pre-eclamptic pathophysiology and its translational possibilities for clinical prediction and diagnosis.
Palmer KR; Tong S; Kaitu'u-Lino TJ
Mol Hum Reprod; 2017 Feb; 23(2):69-78. PubMed ID: 27986932
[TBL] [Abstract][Full Text] [Related]
5. Placental Growth Factor Administration Abolishes Placental Ischemia-Induced Hypertension.
Spradley FT; Tan AY; Joo WS; Daniels G; Kussie P; Karumanchi SA; Granger JP
Hypertension; 2016 Apr; 67(4):740-7. PubMed ID: 26831193
[TBL] [Abstract][Full Text] [Related]
6. Oxygen and placental development during the first trimester: implications for the pathophysiology of pre-eclampsia.
Caniggia I; Winter J; Lye SJ; Post M
Placenta; 2000; 21 Suppl A():S25-30. PubMed ID: 10831118
[TBL] [Abstract][Full Text] [Related]
7. Potential cell signalling mechanisms involved in differential placental angiogenesis in mild and severe pre-eclampsia.
Escudero C; Puebla C; Westermeier F; Sobrevia L
Curr Vasc Pharmacol; 2009 Oct; 7(4):475-85. PubMed ID: 19485894
[TBL] [Abstract][Full Text] [Related]
8. Relationships of serum placental growth factor and soluble fms-like tyrosine kinase-1 with fetal and uterine artery Doppler indices in pre-eclampsia.
Li J; Cai A; Yuan Q; Ding H; Zhao D
Int J Gynaecol Obstet; 2019 May; 145(2):176-181. PubMed ID: 30801711
[TBL] [Abstract][Full Text] [Related]
9. Contrasting effects of chronic hypoxia and nitric oxide synthase inhibition on circulating angiogenic factors in a rat model of growth restriction.
Bahtiyar MO; Buhimschi C; Ravishankar V; Copel J; Norwitz E; Julien S; Guller S; Buhimschi IA
Am J Obstet Gynecol; 2007 Jan; 196(1):72.e1-6. PubMed ID: 17240241
[TBL] [Abstract][Full Text] [Related]
10. Soluble fms-like tyrosine kinase-1 to placental growth factor ratio: ruling out pre-eclampsia for up to 4 weeks and value of retesting.
Zeisler H; Llurba E; Chantraine FJ; Vatish M; Staff AC; Sennström M; Olovsson M; Brennecke SP; Stepan H; Allegranza D; Schoedl M; Grill S; Hund M; Verlohren S
Ultrasound Obstet Gynecol; 2019 Mar; 53(3):367-375. PubMed ID: 30014562
[TBL] [Abstract][Full Text] [Related]
11. Melatonin and stable circadian rhythms optimize maternal, placental and fetal physiology.
Reiter RJ; Tan DX; Korkmaz A; Rosales-Corral SA
Hum Reprod Update; 2014; 20(2):293-307. PubMed ID: 24132226
[TBL] [Abstract][Full Text] [Related]
12. Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women.
Rajakumar A; Michael HM; Rajakumar PA; Shibata E; Hubel CA; Karumanchi SA; Thadhani R; Wolf M; Harger G; Markovic N
Placenta; 2005 Aug; 26(7):563-73. PubMed ID: 15993706
[TBL] [Abstract][Full Text] [Related]
13. Angiogenic growth factor levels in maternal and fetal blood: correlation with Doppler ultrasound parameters in pregnancies complicated by pre-eclampsia and intrauterine growth restriction.
Schlembach D; Wallner W; Sengenberger R; Stiegler E; Mörtl M; Beckmann MW; Lang U
Ultrasound Obstet Gynecol; 2007 Apr; 29(4):407-13. PubMed ID: 17330322
[TBL] [Abstract][Full Text] [Related]
14. Placental ischaemia is a consequence rather than a cause of pre-eclampsia.
Ayuk PT; Matijevic R
Med Hypotheses; 2006; 67(4):792-5. PubMed ID: 16762513
[TBL] [Abstract][Full Text] [Related]
15. Liposome-encapsulated hemoglobin (hemoglobin-vesicle) is not transferred from mother to fetus at the late stage of pregnancy in the rat model.
Kaga M; Li H; Ohta H; Taguchi K; Ogaki S; Izumi H; Inagaki M; Tsuchiya S; Okamura K; Otagiri M; Sakai H; Yaegashi N
Life Sci; 2012 Oct; 91(11-12):420-428. PubMed ID: 22935405
[TBL] [Abstract][Full Text] [Related]
16. Endothelin-l in feto-placental tissues from normotensive pregnant women and women with pre-eclampsia.
Singh HJ; Rahman A; Larmie ET; Nila A
Acta Obstet Gynecol Scand; 2001 Feb; 80(2):99-103. PubMed ID: 11167202
[TBL] [Abstract][Full Text] [Related]
17. Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia.
Molvarec A; Szarka A; Walentin S; Szucs E; Nagy B; Rigó J
Hypertens Res; 2010 Sep; 33(9):892-8. PubMed ID: 20535121
[TBL] [Abstract][Full Text] [Related]
18. Placental Regulation of Inflammation and Hypoxia after TNF-α Infusion in Mice.
Bobek G; Surmon L; Mirabito KM; Makris A; Hennessy A
Am J Reprod Immunol; 2015 Nov; 74(5):407-18. PubMed ID: 26220019
[TBL] [Abstract][Full Text] [Related]
19. Stereological investigation of placental morphology in pregnancies complicated by pre-eclampsia with and without intrauterine growth restriction.
Mayhew TM; Ohadike C; Baker PN; Crocker IP; Mitchell C; Ong SS
Placenta; 2003; 24(2-3):219-26. PubMed ID: 12566249
[TBL] [Abstract][Full Text] [Related]
20. Circulating angiogenic factors in pregnancies complicated by pre-eclampsia.
Varughese B; Bhatla N; Kumar R; Dwivedi SN; Dhingra R
Natl Med J India; 2010; 23(2):77-81. PubMed ID: 20925202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
